Chemoinformaics analysis of Spirostan-1,3-diol, (1beta,3beta,5alpha,25S)-
| Molecular Weight | 432.645 | nRot | 0 |
| Heavy Atom Molecular Weight | 388.293 | nRig | 30 |
| Exact Molecular Weight | 432.324 | nRing | 6 |
| Solubility: LogS | -5.083 | nHRing | 2 |
| Solubility: LogP | 5.057 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 77.6369 |
| nHD | 2 | BPOL | 47.6131 |
| QED | 0.579 |
| Synth | 5.45 |
| Natural Product Likeliness | 3.375 |
| NR-PPAR-gamma | 0.067 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.992 |
| Pgp-sub | 0.988 |
| HIA | 0.004 |
| CACO-2 | -4.829 |
| MDCK | 0.0000161 |
| BBB | 0.361 |
| PPB | 0.699461 |
| VDSS | 1.724 |
| FU | 0.122147 |
| CYP1A2-inh | 0.049 |
| CYP1A2-sub | 0.533 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.769 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.041 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.289 |
| CYP3a4-inh | 0.436 |
| CYP3a4-sub | 0.296 |
| CL | 16.015 |
| T12 | 0.131 |
| hERG | 0.983 |
| Ames | 0.034 |
| ROA | 0.592 |
| SkinSen | 0.963 |
| Carcinogencity | 0.456 |
| EI | 0.221 |
| Respiratory | 0.938 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.714208 |